Population pharmacokinetic and dynamic models: Parametric (P) and nonparametric (NP)approaches

被引:5
|
作者
Jelliffe, R [1 ]
Schumitzky, A [1 ]
Van Guilder, M [1 ]
Wang, X [1 ]
Leary, R [1 ]
机构
[1] Univ Calif Los Angeles, Sch Med, Lab Appl Pharmacokinet, Los Angeles, CA 90024 USA
关键词
D O I
10.1109/CBMS.2001.941754
中图分类号
TP18 [人工智能理论];
学科分类号
081104 ; 0812 ; 0835 ; 1405 ;
摘要
With P models, the probability distributions of each PK/PD model parameter are described as means and covariances, as estimators of the central tendency and the dispersion. With NP models, however, no assumptions at all are made about the shape of the parameter distributions. This robust approach has the point of view, that the very best (the ideal) population model would be the correct structural model, plus the entire collection of each subject's exactly known parameter values, if it were somehow possible to know them. NP methods resolve the results into tip to one set of parameter values for each subject, along with an estimated probability for each parameter set. The strength of the method is its ability to estimate the entire population parameter joint density with maximum likelihood. Optimal population modeling currently begins by determining the assay error pattern explicitly over its working range. Next, one currently uses a P population modeling method to separate intra- from inter-individual variability. One can then use this information in an NP approach to estimate the entire population parameter discrete joint density. NP models lend themselves naturally to "multiple model" (MM) dosage design for maximally precise regimens for optimal patient care.
引用
收藏
页码:407 / 412
页数:6
相关论文
共 50 条
  • [31] INFORMATION AND ASYMPTOTIC EFFICIENCY IN PARAMETRIC NONPARAMETRIC MODELS
    BEGUN, JM
    HALL, WJ
    HUANG, WM
    WELLNER, JA
    ANNALS OF STATISTICS, 1983, 11 (02): : 432 - 452
  • [32] APPLICATION OF NONPARAMETRIC POPULATION PHARMACOKINETIC ANALYSIS TO BALANCED DATA
    BAILEY, JM
    ANESTHESIOLOGY, 1994, 81 (3A) : A412 - A412
  • [33] Parametric Approaches in Population Pharmacokinetics
    Guidi, Monia
    Csajka, Chantal
    Buclin, Thierry
    JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 62 (02): : 125 - 141
  • [34] Validation of population pharmacokinetic models: a comparison of internal and external validation approaches for hydrochlorothiazide
    Kousovista, Rania
    Karali, Georgia
    Vlasopoulou, Katerina
    Karalis, Vangelis
    XENOBIOTICA, 2021, 51 (12) : 1372 - 1388
  • [35] GENTAMICIN POPULATION PHARMACOKINETIC MODELS FOR LOW-BIRTH-WEIGHT INFANTS USING A NEW NONPARAMETRIC METHOD
    DODGE, WF
    JELLIFFE, RW
    RICHARDSON, J
    MCCLEERY, RA
    HOKANSON, JA
    SNODGRASS, WR
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1991, 50 (01) : 25 - 31
  • [36] Parametric and nonparametric population methods - The author's reply
    Jelliffe, Roger
    CLINICAL PHARMACOKINETICS, 2006, 45 (08) : 852 - 854
  • [37] Population pharmacokinetics/pharmacodynamics modeling: Parametric and nonparametric methods
    Jelliffe, R
    Schumitzky, A
    Van Guilder, M
    THERAPEUTIC DRUG MONITORING, 2000, 22 (03) : 354 - 365
  • [38] Inference for cumulative incidence quantiles via parametric and nonparametric approaches
    Lee, Minjung
    Fine, Jason P.
    STATISTICS IN MEDICINE, 2011, 30 (27) : 3221 - 3235
  • [39] Analysis of food consumption patterns in China: Nonparametric and parametric approaches
    Fan J.X.
    Chern W.S.
    Journal of Family and Economic Issues, 1997, 18 (2) : 113 - 126
  • [40] PARAMETRIC VERSUS NONPARAMETRIC APPROACHES TO INDIVIDUAL-DIFFERENCES SCALING
    MAYDEUOLIVARES, A
    PSICOTHEMA, 1994, 6 (02) : 297 - 310